e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
The European Respiratory Review 2010 updates: whats hot in pulmonary medicine?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD: more treatments but no cure?
N. Roche (Paris, France)
Source:
Annual Congress 2011 - The European Respiratory Review 2010 updates: whats hot in pulmonary medicine?
Session:
The European Respiratory Review 2010 updates: whats hot in pulmonary medicine?
Session type:
Symposium
Number:
1337
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Roche (Paris, France). COPD: more treatments but no cure?. Annual Congress 2011 - The European Respiratory Review 2010 updates: whats hot in pulmonary medicine?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Antibiotics for stable COPD: are we there yet?
Source: Annual Congress 2010 - PG11 Postgraduate Course: Infection: a player in the natural history of COPD
Year: 2010
COPD: An outcome of childhood asthma?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010
COPD exacerbations and adherence to treatment improvement:what goal can be achieved?
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
More hope for cure by individualised adjuvant treatment?
Source: Annual Congress 2010 - Customised chemotherapy for lung cancer
Year: 2010
Management of GOR: drugs versus surgery?
Source: Annual Congress 2010 - PG21 Postgraduate Course: Is gastro-oesophageal reflux bad for the lungs?
Year: 2010
Optimising bronchodilator therapy in COPD: Who, why and when?
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019
Use of alternative therapies in patients with asthma and COPD: is there any difference?
Source: Eur Respir J 2005; 26: Suppl. 49, 504s
Year: 2005
Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Spirometry parameters and adherence to COPD treatment: is there association?
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
Improving symptomology in COPD: which therapy would you choose, a brochodilator or pulmonary rehabilitation?
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Enough is enough: misuse of NIV in the treatment of chronic patients with exacerbation of symptoms?
Source: Annual Congress 2013 –The dark side of the moon: when, why, and where I should not use NIV?
Year: 2013
Evaluating disease-modifying treatment in CF: are we ready to take the challenge?
Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases"
Year: 2014
What is COPD? What is asthma?
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Treatment of COPD and the TOnado trial: a tempest in a teapot?
Source: Eur Respir J 2015; 45: 869-871
Year: 2015
Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept